Le Gia Investment Group JSC (HNX:KDM)

Ligand Pharmaceuticals Income Statement

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	28,522	35,660	74,682	43,966	21,207	12,057
Revenue Growth (YoY)	-48.13%	-52.25%	69.86%	107.32%	75.89%	-75.61%
Cost of Revenue	27,514	34,326	72,644	42,416	20,039	11,869
Gross Profit	1,008	1,334	2,037	1,550	1,168	187.37
Selling, General & Admin	1,418	1,607	1,350	1,208	1,722	2,042
Operating Expenses	1,418	1,607	1,350	1,208	1,722	2,042
Operating Income	-409.2	-273.47	687.46	342.3	-554.26	-1,855
Interest Expense	-	-129.89	-95.92	-	-	-
Interest & Investment Income	1,038	1,381	1,588	1,560	1,646	1,486
Other Non Operating Income (Expenses)	447.77	447.77	47.04	-5,029	-28.09	-1,503
EBT Excluding Unusual Items	1,077	1,425	2,226	-3,127	1,064	-1,872
Gain (Loss) on Sale of Investments	115.21	185.52	-51.93	-	-	-
Pretax Income	1,192	1,611	2,174	-3,127	1,064	-1,872
Income Tax Expense	245.78	314.11	557.94	-	193.49	-
Net Income	946.15	1,297	1,617	-3,127	870.46	-1,872
Net Income to Common	946.15	1,297	1,617	-3,127	870.46	-1,872
Net Income Growth	-22.83%	-19.78%	-	-	-	-
Shares Outstanding (Basic)	8	8	8	8	8	-
Shares Outstanding (Diluted)	8	8	8	8	8	-
Shares Change (YoY)	0.01%	-	-0.00%	-0.20%	-	-
EPS (Basic)	124.54	170.69	212.79	-411.61	114.35	-
EPS (Diluted)	124.54	170.69	212.79	-411.61	114.35	-
EPS Growth	-22.83%	-19.78%	-	-	-	-
Free Cash Flow	5,255	7,841	-9,860	8,231	-5,979	-11,903
Free Cash Flow Per Share	691.65	1032.14	-1297.89	1083.47	-785.35	-
Gross Margin	3.54%	3.74%	2.73%	3.53%	5.51%	1.55%
Operating Margin	-1.44%	-0.77%	0.92%	0.78%	-2.61%	-15.39%
Profit Margin	3.32%	3.64%	2.17%	-7.11%	4.11%	-15.53%
Free Cash Flow Margin	18.42%	21.99%	-13.20%	18.72%	-28.19%	-98.73%
EBIT	-409.2	-273.47	687.46	342.3	-554.26	-1,855
EBIT Margin	-1.44%	-0.77%	0.92%	0.78%	-2.61%	-15.39%
Effective Tax Rate	20.62%	19.50%	25.66%	-	18.19%	-
Revenue as Reported	28,522	35,660	74,682	43,966	21,207	12,057

Updated Jan 22, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.